Bill would exempt joint drug price negotiations

Citing pharmaceutical spending as nearly 20% of healthcare costs in the US, a congressman has proposed a safe harbour from antitrust liability for private health insurers to jointly negotiate wholesale prices for prescription drugs.

Unlock unlimited access to all Global Competition Review content